QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
NASDAQ:REPL

Replimune Group (REPL) News Today

$18.48
-0.51 (-2.69%)
(As of 06/1/2023 ET)
Compare
Today's Range
$18.40
▼
$19.11
50-Day Range
$15.65
▼
$19.78
52-Week Range
$13.84
▼
$29.52
Volume
176,082 shs
Average Volume
544,215 shs
Market Capitalization
$1.07 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$51.60
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability
Get Replimune Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter.



REPL Media Mentions By Week

REPL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REPL
News Sentiment
▼
0.32

0.47
▲
Average
Medical
News Sentiment

REPL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REPL Articles
This Week
▼
7

2
▲
REPL Articles
Average Week

SourceHeadline
finance.yahoo.com logoReplimune to Present at the Jefferies Global Healthcare Conference
finance.yahoo.com - June 1 at 4:57 PM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - June 1 at 6:51 AM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Schroder Investment Management Group
marketbeat.com - May 31 at 7:30 AM
markets.businessinsider.com logoSVB Securities Reaffirms Their Buy Rating on Replimune Group (REPL)
markets.businessinsider.com - May 29 at 5:39 PM
msn.com logoEF Hutton Reiterates Replimune Group (REPL) Buy Recommendation
msn.com - May 26 at 10:34 PM
MarketBeat logoFY2024 EPS Estimates for Replimune Group, Inc. (NASDAQ:REPL) Cut by Wedbush
americanbankingnews.com - May 26 at 2:22 AM
finance.yahoo.com logoReplimune to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - May 25 at 9:32 PM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Swiss National Bank
marketbeat.com - May 25 at 4:44 AM
MarketBeat logoReplimune Group, Inc. (NASDAQ:REPL) Expected to Earn Q1 2024 Earnings of ($0.87) Per Share
americanbankingnews.com - May 25 at 1:38 AM
markets.businessinsider.com logoBMO Capital Keeps Their Buy Rating on Replimune Group (REPL)
markets.businessinsider.com - May 23 at 8:34 AM
marketbeat.com logoWedbush Comments on Replimune Group, Inc.'s Q1 2024 Earnings (NASDAQ:REPL)
marketbeat.com - May 23 at 5:57 AM
marketbeat.com logoVictory Capital Management Inc. Buys New Shares in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - May 23 at 5:38 AM
msn.com logoWedbush Reiterates Replimune Group (REPL) Outperform Recommendation
msn.com - May 22 at 8:24 PM
MarketBeat logoReplimune Group, Inc. (NASDAQ:REPL) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - May 22 at 3:40 AM
MarketBeat logoJean M. Franchi Sells 11,351 Shares of Replimune Group, Inc. (NASDAQ:REPL) Stock
americanbankingnews.com - May 20 at 6:04 AM
MarketBeat logoReplimune Group, Inc. (NASDAQ:REPL) CEO Philip Astley-Sparke Sells 17,902 Shares
americanbankingnews.com - May 20 at 5:30 AM
marketbeat.com logoLetko Brosseau & Associates Inc. Lowers Holdings in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - May 19 at 12:08 PM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Teva Pharmaceutical (TEVA) and Replimune Group (REPL)
markets.businessinsider.com - May 18 at 11:29 PM
marketwatch.com logoReplimune Group Chief Financial Officer Jean Franchi Resigns >REPL
marketwatch.com - May 18 at 1:27 PM
msn.com logoRecap: Replimune Group Q4 Earnings
msn.com - May 18 at 1:27 PM
finance.yahoo.com logoReplimune Reports Fiscal Fourth Quarter and Year Ended 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - May 18 at 8:27 AM
finance.yahoo.com logoIs a Surprise Coming for Replimune (REPL) This Earnings Season?
finance.yahoo.com - May 17 at 3:22 PM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Buy" by Analysts
marketbeat.com - May 17 at 1:44 AM
finance.yahoo.com logoReplimune to Participate in the Piper Sandler Spring Biopharma Symposium
finance.yahoo.com - May 9 at 12:56 PM
marketbeat.com logoTD Asset Management Inc Raises Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - May 8 at 5:32 AM
marketbeat.com logoProShare Advisors LLC Buys Shares of 9,341 Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - May 4 at 5:00 AM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Bought by Frazier Life Sciences Management L.P.
marketbeat.com - May 1 at 5:21 AM
marketbeat.com logoFisher Asset Management LLC Purchases 14,826 Shares of Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - April 28 at 5:46 AM
MarketBeat logoReplimune Group, Inc. (NASDAQ:REPL) Receives $51.67 Average Price Target from Brokerages
americanbankingnews.com - April 25 at 1:32 AM
MarketBeat logoReplimune Group (NASDAQ:REPL) Rating Reiterated by Piper Sandler
americanbankingnews.com - April 20 at 5:24 AM
markets.businessinsider.com logoReplimune Group (REPL) Receives a Buy from Piper Sandler
markets.businessinsider.com - April 17 at 8:05 AM
MarketBeat logoReplimune Group (NASDAQ:REPL) Trading Down 3.5%
americanbankingnews.com - April 12 at 8:32 AM
MarketBeat logoReplimune Group, Inc. (NASDAQ:REPL) Receives Average Recommendation of "Buy" from Analysts
americanbankingnews.com - April 2 at 2:24 AM
MarketBeat logoaTyr Pharma (NASDAQ:LIFE) versus Replimune Group (NASDAQ:REPL) Critical Review
americanbankingnews.com - April 1 at 3:58 AM
finance.yahoo.com logoDown -22% in 4 Weeks, Here's Why Replimune Group, Inc. (REPL) Looks Ripe for a Turnaround
finance.yahoo.com - March 31 at 3:06 PM
marketbeat.com logoMoody Aldrich Partners LLC Buys New Shares in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - March 31 at 2:38 PM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Receives Average Rating of "Buy" from Analysts
marketbeat.com - March 28 at 2:18 AM
seekingalpha.com logoREPL Replimune Group, Inc.
seekingalpha.com - March 17 at 6:48 PM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Sold by Price T Rowe Associates Inc. MD
marketbeat.com - March 14 at 4:58 AM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Sold by Price T Rowe Associates Inc. MD
marketbeat.com - March 14 at 4:58 AM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Ensign Peak Advisors Inc
marketbeat.com - March 13 at 5:29 AM
marketbeat.com logoPoint72 Asset Management L.P. Trims Holdings in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - March 3 at 6:01 AM
marketbeat.com logoReplimune Group, Inc. (NASDAQ:REPL) Receives Average Rating of "Buy" from Brokerages
marketbeat.com - March 3 at 2:19 AM
finance.yahoo.com logoReplimune Group, Inc. (REPL) Loses -14.58% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
finance.yahoo.com - February 24 at 6:18 PM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Increases Stake in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - February 22 at 5:09 AM
marketbeat.com logoHC Wainwright Raises Replimune Group (NASDAQ:REPL) Price Target to $50.00
marketbeat.com - February 10 at 11:57 AM
marketbeat.com logoBarclays PLC Raises Holdings in Replimune Group, Inc. (NASDAQ:REPL)
marketbeat.com - February 10 at 4:35 AM
msn.com logoReplimune Group GAAP EPS of -$0.69 beats by $0.08
msn.com - February 9 at 9:43 AM
finance.yahoo.com logoReplimune Reports Fiscal Third Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - February 9 at 9:43 AM
finance.yahoo.com logoReplimune to Present at the Virtual SVB Securities Global Biopharma Conference
finance.yahoo.com - February 7 at 9:23 AM
Get Replimune Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:REPL) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -